ClinicalTrials.gg
CompletedNCT07874477Updated Oct 20, 2026

DHS Fixation for Extra Capsular Fractures of Proximal Femur in Geriatric Population

An interventional study of Early weight bearing and Delayed mobilization in Intertrochanteric Femoral Fracture, sponsored by Hayat Abad Medical Complex, Peshawar. Completed at 1 site in Pakistan. Open to participants aged 60 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-10-20.

Sponsored by Hayat Abad Medical Complex, Peshawar · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled Apr 2026, registered Oct 2026).
Updated Oct 20, 2026Eligibility revisedPrimary outcomes revised+1 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
60 Years to 85 Years
Sex
All
01

Study summary

This study compares two approaches to starting walking and weight bearing after surgery for a fracture near the hip in older adults. All participants undergo fixation with a dynamic hip screw, a metal implant that holds the broken bone in position while it heals.

Ninety participants are randomly assigned to two equal groups. One group starts weight bearing during the first week after surgery. The other group delays mobilization until after the first week. Both groups receive routine postoperative care and physiotherapy.

The study aims to determine whether earlier weight bearing improves pain, walking ability, and everyday activities. Recovery is assessed using the Modified Harris Hip Score at six weeks and three months after surgery. Postoperative complications are also recorded.

Read the detailed description

This single-center, randomized controlled trial is conducted in the Department of Orthopaedics and Spine Surgery at Hayatabad Medical Complex, Peshawar, Pakistan. It compares early weight bearing with delayed mobilization following dynamic hip screw fixation of intertrochanteric femoral fractures in older adults.

Ninety participants are assigned in a 1:1 ratio using blocked randomization. The early weight-bearing group begins weight bearing within the first postoperative week, while the delayed-mobilization group begins mobilization after the first postoperative week.

Both groups undergo closed fracture reduction under fluoroscopic guidance followed by fixation with a dynamic hip screw and side plate through a lateral approach. Routine postoperative care includes antibiotics, analgesia, thromboprophylaxis, wound care, and physiotherapy. The planned difference between groups is the timing of postoperative weight bearing and mobilization.

Functional recovery is assessed at six weeks and three months using the Modified Harris Hip Score, which evaluates pain, walking, and activities of daily living. Postoperative complications are recorded during follow-up.

02

Conditions studied

  • Intertrochanteric Femoral Fracture

Browse trials for

Keywords

  • Hip fracture
  • Dynamic hip screw
  • DHS fixation
  • Early weight bearing
  • Delayed mobilization
  • Postoperative rehabilitation
03

In context

Hip Fractures

848 studies on the registry are indexed under Hip Fractures; 160 are open to participants now.

This study's enrollment of 90 is close to the median of 90 across 540 interventional studies indexed under Hip Fractures.

Browse Hip Fractures studies →

Lead sponsor

Hayat Abad Medical Complex, Peshawar is the lead sponsor of 13 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age within the eligibility range specified in the approved protocol.
  • Male or female.
  • Radiologically confirmed intertrochanteric femoral fracture.
  • Undergoing dynamic hip screw fixation.

Exclusion criteria

Exclusion Criteria:

  • Pre-existing contractures.
  • Open fractures.
  • Pathological fractures.
  • Polytrauma.
  • Associated neurovascular injuries.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (actual)

Study arms

  • Experimental
    Early Weight Bearing

    Participants undergo dynamic hip screw fixation for an intertrochanteric femoral fracture and begin weight bearing within the first postoperative week. They receive routine postoperative care, including antibiotics, analgesia, thromboprophylaxis, wound care, and physiotherapy. Functional recovery is assessed using the Modified Harris Hip Score at six weeks and three months after surgery.

    Other: Early weight bearing

  • Active comparator
    Delayed Mobilization

    Participants undergo dynamic hip screw fixation for an intertrochanteric femoral fracture and begin mobilization after the first postoperative week. They receive routine postoperative care, including antibiotics, analgesia, thromboprophylaxis, wound care, and physiotherapy. Functional recovery is assessed using the Modified Harris Hip Score at six weeks and three months after surgery.

    Other: Delayed mobilization

Interventions

  • OtherEarly weight bearing

    Participants begin weight bearing within the first postoperative week following dynamic hip screw fixation of an intertrochanteric femoral fracture. Routine postoperative care and physiotherapy are provided.

  • OtherDelayed mobilization

    Participants begin mobilization after the first postoperative week following dynamic hip screw fixation of an intertrochanteric femoral fracture. Routine postoperative care and physiotherapy are provided.

06

What researchers measure

Primary outcomes

  1. Modified Harris Hip Score

    Functional status assessed using the Modified Harris Hip Score, which evaluates hip pain and function, including walking ability and activities of daily living. Scores range from 0 to 100, with higher scores indicating better hip function. Scores are compared between the early weight-bearing and delayed-mobilization groups at each assessment.

    Time frame: Six weeks and three months after surgery.

07

Study locations

1 site
  • Hayatabad Medical Complex Peshawar
    Peshawar, KPK 25000, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2026 to primary completion in Oct 2026, 5 months.

Of 225 non-industry interventional studies with no phase under Hip Fractures, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 55. This study's 5 months is below that.

Counting every sponsor, half of 239 studies reached it within 29 months; a quarter within 10 and three quarters within 57.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 8, 2026
First posted
Oct 15, 2026
StartActual
Apr 9, 2026
Primary completionActual
Oct 8, 2026
CompletionActual
Oct 8, 2026
Last update
Oct 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Also revised
eligibility and primary outcomes
Registered
First appeared on the registry
Oct 15, 2026
Show all 2 updates
  1. Oct 20, 2026
    Eligibility Minimum age 50 Years→60 Years
    Primary outcomes Revised (1 change)
    + 1 other change: responsible party
  2. Oct 15, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07874477
Lead sponsor
Hayat Abad Medical Complex, Peshawar
Responsible party
Zarar Ahmed (Principal investigator, Hayat Abad Medical Complex, Peshawar) — Principal investigator
First posted
Oct 15, 2026
Start date
Apr 9, 2026
Primary completion
Oct 8, 2026
Completion
Oct 8, 2026
Last update
Oct 20, 2026

Study contacts

Noor Rahman, FCPS
study chair · Hayat Abad Medical Complex, Peshawar

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion